Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos (NYSE:GKOS)

Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.

Related Keywords

Glaukos Corporation , William Blair , Wells Fargo , Jp Morgan , ,